Abstract
The pharmacokinetics of antibiotics such as levofloxacin exhibits large interindividual differences, questioning the value of fixed dose regimens and warranting individual dosing based on therapeutic drug monitoring. Here, in a proof of principal study, it is shown that levofloxacin can be detected in human urine samples by employing lab-on-a-chip surface enhanced Raman spectroscopy (LoC-SERS). First, artificial urine is used as a matrix in order to get insights into the influence of different parameters such as matrix complexity, aggregation time, and matrix dilution on the overall SERS signal. Second, three anonymized individual and three pooled urine samples originating from patients undergoing either no or unknown medical treatments have been spiked with the target analyte. Measurements were performed with a benchtop and a portable Raman setup. In all six samples urinary levofloxacin concentrations between 0.45 mM (162.6 μg/mL) and 1.8 mM (650.5 μg/mL) have been successfully detected. According to the...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call